Video Experimental Relacionado
Updated: Jun 18, 2026
06:26
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
Nanocontenedores sensibles a las enzimas con ciclodextrina como guardianes y efectos sinérgicos en la liberación de
Chiyoung Park1, Hyehyeon Kim, Saehee Kim
1Department of Polymer Science and Engineering, Inha University, Incheon 402-751, Korea.
Journal of the American Chemical Society
|November 19, 2009
Resumen
Las nanopartículas de sílice sensibles a las enzimas con puertas de ciclodextrina liberan moléculas cuando se tratan con alfa-amilasa o lipasa. Esto ofrece un método novedoso para sistemas controlados de administración de fármacos.
Área de la Ciencia:
- Nanotecnología La nanotecnología es la nanotecnología.
- Ciencia de los materiales Ciencia de los materiales.
- La bioquímica es la bioquímica.
Sus antecedentes:
- Las nanopartículas porosas de sílice (Si-MPs) son ampliamente investigadas para la administración de medicamentos.
- El desarrollo de sistemas de respuesta a estímulos es crucial para las aplicaciones de liberación controlada.
- Las ciclodextrinas ofrecen una versátil química huésped-invitado para la encapsulación molecular.
Objetivo del estudio:
- Diseñar nanopartículas de sílice sensibles a las enzimas para la liberación controlada de moléculas invitadas.
- Para investigar los mecanismos de liberación desencadenados por enzimas específicas.
- Establecer una nueva plataforma para sistemas avanzados de administración de fármacos.
Principales métodos:
- Modificación de la superficie de las nanopartículas porosas de sílice con ciclodextrina.
- Hidrólisis enzimática de los guardianes de la ciclodextrina utilizando alfa-amilasa y lipasa.
- Caracterización de la cinética de liberación de moléculas invitadas.
- Análisis de los sitios de escisión dentro de la estructura de la ciclodextrina.
Principales resultados:
- Los Si-MPs cubiertos con ciclodextrina demostraron una liberación enzimática sensible de las moléculas invitadas encapsuladas.
- La alfa-amilasa hidrolizó la ciclodextrina para liberar a los huéspedes del depósito poroso.
- La lipasa rompió el enlace de éster en el tallo de ciclodextrina, liberando a los huéspedes del canal.
- Se confirmó que el mecanismo de liberación es dependiente de la enzima.
Conclusiones:
- Las nanopartículas de sílice sensibles a las enzimas con guardianes de la ciclodextrina proporcionan una plataforma de liberación controlada sintonizable.
- El sistema de respuesta enzimática dual ofrece un control preciso sobre la cinética de liberación de moléculas invitadas.
- Esta metodología presenta un enfoque único para el desarrollo de sofisticados sistemas de administración de fármacos.
Más Videos Relacionados
10:10Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags
Published on: January 17, 2019
10:39Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction
Published on: August 23, 2018
Videos de Conceptos Relacionados
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...